Global PCR-Based Transplant Diagnostics Market - Industry Trends and Forecast to 2031

Description

List of Tables

Global PCR based transplant diagnostics market is expected to reach USD 995,007.52 thousand by 2031, from USD 612,500.00 thousand in 2023 growing at the CAGR of 6.5% in the forecast period of 2024 to 2031.

Market Segmentation

Global PCR based Transplant diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR TestHSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), By Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest Of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa )- Industry Trends and Forecast to 2031

Overview of Global PCR Based Transplant Diagnostics Market Dynamics

Driver
Increasing prevalence of organ failure
Restraint
Shortage of professionals with expertise in transplant diagnostics
Opportunity
Strategic initiation and technology launches by market players

Market Players

Some of the major market players for the global PCR based transplant diagnostics market are:

Quest Diagnostics Incorporated.
Laboratory Corporation of America Holdings.
Eurofins Viracor, LLC
Sonic Healthcare USA
Dr Lal PathLabs
ARUP Laboratories.
Amber Lab

1 INTRODUCTION 21

1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET 21
1.4 CURRENCY AND PRICING 22
1.5 LIMITATIONS 22
1.6 MARKETS COVERED 23

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 DBMR TRIPOD DATA VALIDATION MODEL 28
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.6 MULTIVARIATE MODELLING 32
2.7 TEST TYPE SEGMENT LIFELINE CURVE 32
2.8 MARKET END USER COVERAGE GRID 33
2.9 DBMR MARKET POSITION GRID 34
2.10 VENDOR SHARE ANALYSIS 35
2.11 SECONDARY SOURCES 36
2.12 ASSUMPTIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 39

4.1 PESTAL ANALYSIS 42
4.2 PORTERS FIVE FORCES 43

5 MARKET OVERVIEW 44

5.1 DRIVERS 46
- 5.1.1 INCREASING PREVALENCE OF ORGAN FAILURE 46
- 5.1.2 RISING POPULARITY OF NON-INVASIVE DIAGNOSTIC METHODS 46
- 5.1.3 ADVANCEMENT IN ORGAN PRESERVATIVE TECHNIQUES 47
- 5.1.4 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES 48
5.2 RESTRAINTS 49
- 5.2.1 SHORTAGE OF PROFESSIONALS WITH EXPERTISE IN TRANSPLANT DIAGNOSTICS 49
- 5.2.2 HIGH COST OF PCR/NGS SOFTWARE 49
5.3 OPPORTUNITIES 50
- 5.3.1 STRATEGIC INITIATION AND TECHNOLOGY LAUNCHES BY MARKET PLAYERS 50
- 5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR PCR-BASED ORGAN TRANSPLANTATION 50
- 5.3.3 SURGE OF AWARENESS FOR ORGAN TRANSPLANTATION 51
5.4 CHALLENGES 52
- 5.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION 52
- 5.4.2 LACK OF ORGAN DONORS AND PROVIDERS ANNUALLY 53

6 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE 54

6.1 OVERVIEW 55
6.2 CMV PCR TEST 59
6.3 EBV PCR TEST 59
6.4 BKV PCR TEST 59
6.5 VZV PCR TEST 60
6.6 HSV1 PCR TEST 61
6.7 HSV2 PCR TEST 61
6.8 PARVOVIRUS B19 PCR TEST 61
6.9 P. JIROVECII PCR TEST 62
6.10 JCV PCR TEST 63
6.11 ADENOVIRUS PCR TEST 63
6.12 ASPERGILLUS SPP PCR TEST 64

7 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 65

7.1 OVERVIEW 66
7.2 KIDNEY TRANSPLANTATION 69
7.3 LIVER TRANSPLANTATION 70
7.4 HEART TRANSPLANTATION 70
7.5 LUNG TRANSPLANTATION 71
7.6 PANCREAS TRANSPLANTATION 71
7.7 OTHER TRANSPLANTATIONS 72

8 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 73

8.1 OVERVIEW 74
8.2 DIAGNOSTIC APPLICATIONS 77
8.3 RESEARCH APPLICATIONS 78

9 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER 79

9.1 OVERVIEW 80
9.2 HOSPITALS AND TRANSPLANT CENTERS 83
9.3 COMMERCIAL SERVICE PROVIDERS 84
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 84

10 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION 85

10.1 OVERVIEW 86
10.2 NORTH AMERICA 89
- 10.2.1 U.S. 92
- 10.2.2 CANADA 94
- 10.2.3 MEXICO 96
10.3 EUROPE 98
- 10.3.1 FRANCE 101
- 10.3.2 U.K. 103
- 10.3.3 SPAIN 105
- 10.3.4 GERMANY 107
- 10.3.5 TURKEY 109
- 10.3.6 ITALY 111
- 10.3.7 RUSSIA 113
- 10.3.8 NETHERLANDS 115
- 10.3.9 BELGIUM 117
- 10.3.10 SWITZERLAND 119
- 10.3.11 REST OF EUROPE 121
10.4 ASIA-PACIFIC 122
- 10.4.1 CHINA 125
- 10.4.2 INDIA 127
- 10.4.3 SOUTH KOREA 129
- 10.4.4 AUSTRALIA 131
- 10.4.5 JAPAN 133
- 10.4.6 THAILAND 135
- 10.4.7 PHILIPPINES 137
- 10.4.8 INDONESIA 139
- 10.4.9 MALAYSIA 141
- 10.4.10 SINGAPORE 143
- 10.4.11 REST OF ASIA-PACIFIC 145
10.5 SOUTH AMERICA 146
- 10.5.1 BRAZIL 149
- 10.5.2 ARGENTINA 151
- 10.5.3 REST OF SOUTH AMERICA 153
10.6 MIDDLE EAST AND AFRICA 154
- 10.6.1 SAUDI ARABIA 157
- 10.6.2 ISRAEL 159
- 10.6.3 EGYPT 161
- 10.6.4 SOUTH AFRICA 163
- 10.6.5 U.A.E. 165
- 10.6.6 REST OF MIDDLE EAST AND AFRICA 167

11 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, COMPANY LANDSCAPE 168

11.1 COMPANY SHARE ANALYSIS: GLOBAL 168
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 169
11.3 COMPANY SHARE ANALYSIS: EUROPE 170
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 171

12 SWOT ANALYSIS 172

13 COMPANY PROFILES 173

13.1 QUEST DIAGNOSTICS INCORPORATED. 173
- 13.1.1 COMPANY SNAPSHOT 173
- 13.1.2 REVENUE ANALYSIS 173
- 13.1.3 COMPANY SHARE ANALYSIS 174
- 13.1.4 PRODUCT PORTFOLIO 174
- 13.1.5 RECENT DEVELOPMENTS 175
13.2 LABORATORY CORPORATION OF AMERICA HOLDINGS. 176
- 13.2.1 COMPANY SNAPSHOT 176
- 13.2.2 REVENUE ANALYSIS 176
- 13.2.3 COMPANY SHARE ANALYSIS 177
- 13.2.4 PRODUCT PORTFOLIO 177
- 13.2.5 RECENT DEVELOPMENT 178
13.3 EUROFINS VIRACOR 179
- 13.3.1 COMPANY SNAPSHOT 179
- 13.3.2 COMPANY SHARE ANALYSIS 179
- 13.3.3 PRODUCT PORTFOLIO 180
- 13.3.4 RECENT DEVELOPMENTS 181
13.4 SONIC HEALTHCARE LIMITED 182
- 13.4.1 COMPANY SNAPSHOT 182
- 13.4.2 PRODUCT REVENUE ANALYSIS 182
- 13.4.3 COMPANY SHARE ANALYSIS 183
- 13.4.4 PRODUCT PORTFOLIO 183
- 13.4.5 RECENT DEVELOPMENTS 184
13.5 DR LAL PATHLABS. 185
- 13.5.1 COMPANY SNAPSHOT 185
- 13.5.2 REVENUE ANALYSIS 185
- 13.5.3 COMPANY SHARE ANALYSIS 186
- 13.5.4 PRODUCT PORTFOLIO 186
- 13.5.5 RECENT DEVELOPMENTS 187
13.6 ARUP LABORATORIES 188
- 13.6.1 COMPANY SNAPSHOT 188
- 13.6.2 PRODUCT PORTFOLIO 188
- 13.6.3 RECENT DEVELOPMENT 188
13.7 AMBAR LAB. 189
- 13.7.1 COMPANY SNAPSHOT 189
- 13.7.2 PRODUCT PORTFOLIO 189
- 13.7.3 RECENT DEVELOPMENTS 189

14 QUESTIONNAIRE 190

15 RELATED REPORTS 193

LIST OF TABLES

TABLE 1 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 58
TABLE 2 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 58
TABLE 3 GLOBAL CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 4 GLOBAL EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 5 GLOBAL BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 6 GLOBAL VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 7 GLOBAL HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 8 GLOBAL HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 9 GLOBAL PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
TABLE 10 GLOBAL P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
TABLE 11 GLOBAL JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 63
TABLE 12 GLOBAL ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 63
TABLE 13 GLOBAL ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 64
TABLE 14 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 69
TABLE 15 GLOBAL KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 69
TABLE 16 GLOBAL LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 70
TABLE 17 GLOBAL HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 70
TABLE 18 GLOBAL LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 71
TABLE 19 GLOBAL PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 71
TABLE 20 GLOBAL OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 72
TABLE 21 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 77
TABLE 22 GLOBAL DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 77
TABLE 23 GLOBAL RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 78
TABLE 24 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 83
TABLE 25 GLOBAL HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 83
TABLE 26 GLOBAL COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 84
TABLE 27 GLOBAL RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 84
TABLE 28 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 88
TABLE 29 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 89
TABLE 30 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 89
TABLE 31 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 90
TABLE 32 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 90
TABLE 33 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 90
TABLE 34 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 91
TABLE 35 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 92
TABLE 36 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 92
TABLE 37 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 93
TABLE 38 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 93
TABLE 39 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 93
TABLE 40 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 94
TABLE 41 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 94
TABLE 42 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 95
TABLE 43 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 95
TABLE 44 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 95
TABLE 45 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 96
TABLE 46 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 96
TABLE 47 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 97
TABLE 48 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 97
TABLE 49 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 97
TABLE 50 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 98
TABLE 51 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 98
TABLE 52 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 99
TABLE 53 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 99
TABLE 54 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 99
TABLE 55 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 100
TABLE 56 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 101
TABLE 57 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 101
TABLE 58 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 102
TABLE 59 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 102
TABLE 60 FRANCE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 102
TABLE 61 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 103
TABLE 62 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 103
TABLE 63 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 104
TABLE 64 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 104
TABLE 65 U.K. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 104
TABLE 66 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 105
TABLE 67 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 105
TABLE 68 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 106
TABLE 69 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 106
TABLE 70 SPAIN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 106
TABLE 71 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 107
TABLE 72 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 107
TABLE 73 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 108
TABLE 74 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 108
TABLE 75 GERMANY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 108
TABLE 76 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 109
TABLE 77 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 109
TABLE 78 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 110
TABLE 79 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 110
TABLE 80 TURKEY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 110
TABLE 81 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 111
TABLE 82 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 111
TABLE 83 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 112
TABLE 84 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 112
TABLE 85 ITALY PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 112
TABLE 86 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 113
TABLE 87 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 113
TABLE 88 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 114
TABLE 89 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 114
TABLE 90 RUSSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 114
TABLE 91 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 115
TABLE 92 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 115
TABLE 93 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 116
TABLE 94 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 116
TABLE 95 NETHERLANDS PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 116
TABLE 96 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 117
TABLE 97 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 117
TABLE 98 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 118
TABLE 99 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 118
TABLE 100 BELGIUM PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 118
TABLE 101 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 119
TABLE 102 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 119
TABLE 103 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 120
TABLE 104 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 120
TABLE 105 SWITZERLAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 120
TABLE 106 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 121
TABLE 107 REST OF EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 121
TABLE 108 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 122
TABLE 109 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 122
TABLE 110 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 123
TABLE 111 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 123
TABLE 112 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 123
TABLE 113 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 124
TABLE 114 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 125
TABLE 115 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 125
TABLE 116 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 126
TABLE 117 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 126
TABLE 118 CHINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 126
TABLE 119 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 127
TABLE 120 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 127
TABLE 121 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 128
TABLE 122 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 128
TABLE 123 INDIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 128
TABLE 124 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 129
TABLE 125 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 129
TABLE 126 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 130
TABLE 127 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 130
TABLE 128 SOUTH KOREA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 130
TABLE 129 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 131
TABLE 130 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 131
TABLE 131 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 132
TABLE 132 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 132
TABLE 133 AUSTRALIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 132
TABLE 134 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 133
TABLE 135 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 133
TABLE 136 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 134
TABLE 137 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 134
TABLE 138 JAPAN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 134
TABLE 139 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 135
TABLE 140 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 135
TABLE 141 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 136
TABLE 142 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 136
TABLE 143 THAILAND PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 136
TABLE 144 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 137
TABLE 145 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 137
TABLE 146 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 138
TABLE 147 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 138
TABLE 148 PHILIPPINES PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 138
TABLE 149 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 139
TABLE 150 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 139
TABLE 151 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 140
TABLE 152 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 140
TABLE 153 INDONESIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 140
TABLE 154 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 141
TABLE 155 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 141
TABLE 156 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 142
TABLE 157 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 142
TABLE 158 MALAYSIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 142
TABLE 159 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 143
TABLE 160 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 143
TABLE 161 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 144
TABLE 162 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 144
TABLE 163 SINGAPORE PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 144
TABLE 164 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 145
TABLE 165 REST OF ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 145
TABLE 166 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 146
TABLE 167 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 146
TABLE 168 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 147
TABLE 169 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 147
TABLE 170 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 147
TABLE 171 SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 148
TABLE 172 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 149
TABLE 173 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 149
TABLE 174 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 150
TABLE 175 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 150
TABLE 176 BRAZIL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 150
TABLE 177 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 151
TABLE 178 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 151
TABLE 179 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 152
TABLE 180 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 152
TABLE 181 ARGENTINA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 152
TABLE 182 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 153
TABLE 183 REST OF SOUTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 153
TABLE 184 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 154
TABLE 185 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 154
TABLE 186 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 155
TABLE 187 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 155
TABLE 188 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 155
TABLE 189 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 156
TABLE 190 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 157
TABLE 191 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 157
TABLE 192 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 158
TABLE 193 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 158
TABLE 194 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 158
TABLE 195 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 159
TABLE 196 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 159
TABLE 197 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 160
TABLE 198 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 160
TABLE 199 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 160
TABLE 200 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 161
TABLE 201 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 161
TABLE 202 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 162
TABLE 203 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 162
TABLE 204 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 162
TABLE 205 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 163
TABLE 206 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 163
TABLE 207 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 164
TABLE 208 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 164
TABLE 209 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 164
TABLE 210 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 165
TABLE 211 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 165
TABLE 212 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 166
TABLE 213 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 166
TABLE 214 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 166
TABLE 215 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 167
TABLE 216 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 167

LIST OF FIGURES

FIGURE 1 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 25
FIGURE 2 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION 28
FIGURE 3 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS 29
FIGURE 4 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET SHARE ANALYSIS 30
FIGURE 5 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 30
FIGURE 6 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 33
FIGURE 8 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 34
FIGURE 9 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 35
FIGURE 10 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 38
FIGURE 11 INCREASING PREVALENCE OF ORGAN FAILURE IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET FROM 2024 TO 2034 39
FIGURE 12 CMV PCR TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET IN 2024 TO 2031 39
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET AND ASIA-APCIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031 40
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL DIAGNOSTICS TESTS MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2024 TO 2031 41
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET 45
FIGURE 16 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2023 55
FIGURE 17 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND) 56
FIGURE 18 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2024-2031) 56
FIGURE 19 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE LIFELINE CURVE 57
FIGURE 20 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2023 66
FIGURE 21 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2024-2031 (USD THOUSAND) 67
FIGURE 22 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, CAGR (2024-2031) 67
FIGURE 23 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, LIFELINE CURVE 68
FIGURE 24 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2023 74
FIGURE 25 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND) 75
FIGURE 26 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: APPLICATION, CAGR (2024-2031) 75
FIGURE 27 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 76
FIGURE 28 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2023 80
FIGURE 29 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2024-2031 (USD THOUSAND) 81
FIGURE 30 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, CAGR (2024-2031) 81
FIGURE 31 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 82
FIGURE 32 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2023) 87
FIGURE 33 GLOBAL PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 168
FIGURE 34 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 169
FIGURE 35 EUROPE PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 170
FIGURE 36 ASIA-PACIFIC PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 171